Medication Use for Cardiovascular Disease Prevention in 40 Low- and Middle-Income Countries

Cardiovascular disease (CVD) is the leading cause of mortality worldwide, with more than 80% of CVD deaths occurring in low- and middle-income countries (LMICs). Cholesterol-lowering, blood pressure (BP)-lowering, and antiplatelet medications are cost-effective, guideline-recommended treatments to prevent CVD.1 However, the extent to which these medications are used by eligible individuals in LMICs has not been recently described.